these studies substantiated the premise that primary dysmenorrhea is caused by endogenous prostaglandin excess and prompted clinical trials with naproxen sodium ( anaprox ) in patients with primary dysmenorrhea .
C0546873
naproxen sodium
C0699095
anaprox